10-K
COPYTELE 10-K
- Company
- Anixa Biosciences Inc
- Filed
- December 22, 2003
- Period of Report
- October 31, 2003
- Accession Number
- 0001157523-03-007508
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →